CVS Health
CVS
1,762 hedge funds and large institutions have $75.6B invested in CVS Health in 2025 Q2 according to their latest regulatory filings, with 180 funds opening new positions, 634 increasing their positions, 736 reducing their positions, and 156 closing their positions.
20% more call options, than puts
Call options by funds: $2.05B | Put options by funds: $1.7B
19% more capital inflows, than outflows
Capital inflows: $5.38B | Capital outflows: $4.5B
15% more first-time investments, than exits
New positions opened: 180 | Existing positions closed: 156
0.72% more ownership
Funds ownership: 85.99% → 86.71% (+0.72%)
0% more funds holding
Funds holding: 1,759 → 1,762 (+3)
11% less funds holding in top 10
Funds holding in top 10: 38 → 34 (-4)
14% less repeat investments, than reductions
Existing positions increased: 634 | Existing positions reduced: 736
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$965M |
| 2 |
BlackRock
New York
|
+$662M |
| 3 |
JP Morgan Chase
New York
|
+$226M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$204M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$169M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$624M |
| 2 |
Harris Associates
Chicago,
Illinois
|
-$338M |
| 3 |
Glenview Capital Management
New York
|
-$246M |
| 4 |
Holocene Advisors
New York
|
-$233M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$146M |
CVS Hedge Fund Activity: Q2 2025 in Review
1,762 of the 7,624 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2025, worth a combined $75.6B — up 3% from $73.4B a quarter earlier.
Buyers outnumbered sellers: 180 funds opened new CVS positions and 156 closed out — a net gain of 24 holders — while 634 added to existing stakes and 736 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $965M. The largest seller was Capital Research Global Investors, cutting an estimated $624M.
- 1,762 institutional investors held CVS Health (CVS) as of Q2 2025, up from 1,759 in Q1 2025.
- Funds reported $75.6B of CVS Health stock for Q2 2025, up 3% quarter-over-quarter.
- 180 funds opened new CVS Health positions in Q2 2025 and 156 closed out, a net change of +24 holders.
- The largest CVS Health buyer in Q2 2025 was Fidelity Investments, an estimated $965M added.
- The largest CVS Health seller in Q2 2025 was Capital Research Global Investors, an estimated $624M sold.
Based on aggregated 13F filings for Q2 2025.